Lv51
1190 积分 2022-09-16 加入
Discovery and In Vivo Exploration of 1,3,4-Oxadiazole and α-Fluoroacrylate Containing IL-17 Inhibitors
2个月前
已完结
Multicomponent Macrocyclic IL-17a Modifier
2个月前
已完结
Discovery of Small Molecule Interleukin 17A Inhibitors with Novel Binding Mode and Stoichiometry: Optimization of DNA-Encoded Chemical Library Hits to In Vivo Active Compounds
3个月前
已完结
Safety, Tolerability, and Pharmacokinetics of an Oral Small Molecule Inhibitor of IL‐17A (LY3509754): A Phase I Randomized Placebo‐Controlled Study
4个月前
已完结
Potent PROTACs Targeting EGFR Mutants in Drug Discovery
4个月前
已完结
One‐Carbon Ring Expansion of Indoles and Pyrroles: A Straightforward Access to 3‐Fluorinated Quinolines and Pyridines
4个月前
已完结
Abstract 4147: CCX559, an orally administered small molecule PD-L1 inhibitor for the treatment of solid tumors
5个月前
已关闭
CCX559 is a potent, orally-administered small molecule PD-L1 inhibitor that induces anti-tumor immunity
5个月前
已完结
Results of a randomized double-blind placebo-controlled Phase 2 study propose iptacopan as an alternative complement pathway inhibitor for IgA nephropathy
5个月前
已完结
Safety, pharmacokinetics, and pharmacodynamics in healthy Chinese volunteers treated with SC0062, a highly selective endothelin‐A receptor antagonist
6个月前
已完结
皖公网安备34019202002308
